Research
Hormonal
New pharmacologic advances in glucagon-like peptide-1 agonists, such as semaglutide, have shown promising effectiveness for weight management.
Plastic surgeons should consider the role of GLP-1 agonists in managing obesity in surgical patients.
StrongSupportsmedium confidence
New pharmacologic advances in glucagon-like peptide-1 agonists, such as semaglutide, have demonstrated promising effectiveness.
Why this rating
The claim is based on emerging clinical evidence for these medications.
Source
Medical Weight Management Considerations in Plastic Surgery
Alisha B. Paranzino et al. · Plastic & Reconstructive Surgery · 2024
reviewCited 6×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →